Interest of Human Papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions

[1] Munoz N(2003)Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 518-527

[2] Bosch FX(1999)Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 12-19

[3] de Sanjose S(2009)Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV types J Clin Virol 44 302-307

[4] Herrero R(2006)Overview of the European and North American studies on HPV testing in primary cervical cancer screening Int J Cancer 119 1095-1101

[5] Castellsague X(2007)Management of minor cervical cytological abnormalities: a systematic review and a meta-analysis of the literature Cancer Treat Rev 33 514-520

[6] Shah KV(2008)Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries Vaccine 26 K29-K41

[7] Snijders PJ(2008)Use of real-time PCR to detect human papillomavirus-16 viral loads in vaginal and urine self-sampled specimens Clin Microbiol Infect 14 619-621

[8] Meijer CJ(2006)Evaluation of HPV 16 PCR detection in self- compared with clinician-collected samples in women referred for colposcopy Gynecol Oncol 103 463-466

[9] Walboomers JM(2000)Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions CMAJ 163 513-518

[10] Jacobs MV(2013)Vaginal self-sampling is an adequate means of screening HR-HPV types in women not participating in regular cervical cancer screening Clin Microbiol Infect 19 E44-E50

[1] Munoz N(2003)Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 518-527

[2] Bosch FX(1999)Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 12-19

[3] de Sanjose S(2009)Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV types J Clin Virol 44 302-307

[4] Herrero R(2006)Overview of the European and North American studies on HPV testing in primary cervical cancer screening Int J Cancer 119 1095-1101

[5] Castellsague X(2007)Management of minor cervical cytological abnormalities: a systematic review and a meta-analysis of the literature Cancer Treat Rev 33 514-520

[6] Shah KV(2008)Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries Vaccine 26 K29-K41

[7] Snijders PJ(2008)Use of real-time PCR to detect human papillomavirus-16 viral loads in vaginal and urine self-sampled specimens Clin Microbiol Infect 14 619-621

[8] Meijer CJ(2006)Evaluation of HPV 16 PCR detection in self- compared with clinician-collected samples in women referred for colposcopy Gynecol Oncol 103 463-466

[9] Walboomers JM(2000)Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions CMAJ 163 513-518

[10] Jacobs MV(2013)Vaginal self-sampling is an adequate means of screening HR-HPV types in women not participating in regular cervical cancer screening Clin Microbiol Infect 19 E44-E50